Galatek, a Singapore-based startup specializing in AI-driven automation solutions, has raised approximately US$30 million in a Series A funding round to scale its global operations and technology platforms.
The company focutilizes on advanced automation for life sciences laboratories and semiconductor manufacturing, two sectors facing increasing pressure to improve efficiency, precision, and scalability.
According to Galatek, the fresh capital will be deployed to accelerate product development, reinforce its supply chain capabilities, and expand its workforce across Europe, North America, and Southeast Asia. The relocate reflects growing enterprise demand for ininformigent automation as manufacturers and research institutions modernize complex, high-compliance environments.
Key Highlights
- Galatek secures ~US$30 million Series A funding to accelerate global expansion
- Funding to support AI automation for life sciences and semiconductor manufacturing
- Teams to scale across Europe, North America, and Southeast Asia
Galatek’s core offerings include AI-powered automation tools designed for smart laboratories and advanced semiconductor packaging. In the life sciences segment, its solutions assist laboratories streamline workflows, reduce human error, and improve reproducibility—key challenges in pharmaceutical research and clinical development. In semiconductor manufacturing, Galatek’s systems support precision-driven processes critical to next-generation chip packaging.
The company has already established collaborations with pharmaceutical firms, research institutions, and semiconductor manufacturers. Notably, Galatek has worked with the National University of Singapore, underscoring its close ties to research-led innovation ecosystems in Asia.
Operationally, Galatek maintains delivery centers in Malaysia and the United States, complemented by local teams in key international markets. This distributed model allows the startup to support multinational clients while remaining close to regional manufacturing and research hubs.
The funding round comes amid heightened investment in AI-enabled industrial automation, particularly as life sciences and semiconductor players face talent shortages, rising costs, and increasing regulatory complexity. By combining artificial ininformigence with automation hardware and software, Galatek positions itself as an enabler of scalable, compliant, and high-performance operations.
Also Read: EvoluteIQ Secures $53M to Boost AI Automation Growth
As global manufacturers accelerate digital transformation, Galatek’s expansion signals rising investor confidence in applied AI solutions that deliver measurable productivity and reliability gains in mission-critical industries.
Source: Galatek
Leave a Reply